Infant Bacterial Therapeutics
Pharmaceutical Manufacturing • 
Stockholm, Stockholm County, Sweden • 11-20 Employees
Company overview
| Headquarters | Bryggargatan 10, Stockholm, Stockholm County 111 21, SE |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2013 |
| Employees | 11-20 |
| Socials |
Key Contacts at Infant Bacterial Therapeutics
Robert Huhn
Director Manufacturing And Supply
Staffan Stromberg
Ceo
Infant Bacterial Therapeutics Email Formats
Infant Bacterial Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@ibtherapeutics.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@ibtherapeutics.com | 70% |
{first name}.{last name} | john.doe@ibtherapeutics.com | 30% |
About Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB (IBT) is a pharmaceutical company dedicated to developing drugs that prevent diseases in premature infants and combat the spread of antibiotic-resistant illnesses. IBT’s primary focus is on IBP-9414, a drug candidate containing Lactobacillus reuteri, a bacterial strain found in breast milk. The aim of IBP-9414 is to reduce the occurrence of necrotizing enterocolitis (NEC) and improve sustained feeding tolerance (SFT) in premature infants. Currently, IBP-9414 is undergoing a pivotal Phase III study for registration. IBT also has other drug candidates, including IBP-1016 for treating gastroschisis, IBP-1118 for preventing retinopathy of prematurity (ROP), and IBP-1122 for eliminating vancomycin-resistant enterococci (VRE) causing hospital acquired infections. By developing these drugs, IBT addresses medical needs that lack available treatments.
Infant Bacterial Therapeutics revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Infant Bacterial Therapeutics has 7 employees across 6 departments.
Departments
Number of employees
Funding Data
Infant Bacterial Therapeutics has never raised funding before.
Infant Bacterial Therapeutics Tech Stack
Discover the technologies and tools that power Infant Bacterial Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Web servers
Miscellaneous
Form builders
Programming languages
Blogs
Maps
Databases
Miscellaneous
Performance
United States
Portugal
United Kingdom
Brazil
Frequently asked questions
4.8
40,000 users
